Patients with diabetes might be better off with a statin than aspirin

Primary prevention specialist mulls the latest evidence

Three major trials of aspirin for primary prevention of cardiovascular events, viewed together, suggest its benefits are largely outweighed by the bleeding risk, according to a leading Harvard specialist.